-
Drug Price Negotiation Doesn’t Mean the Government Will Restrict Access to Medicines Opens in a new window)
In fact, the proposed drug price negotiation program does not authorize the federal government to decide which medications people on Medicare can and cannot get and does not establish or require a particular prescription drug formulary. -
In U.S., an Estimated 18 Million Can't Pay for Needed Drugs Opens in a new window)
10% have skipped prescribed dosages to preserve drugs and save money.Comments
-
Access to Cancer Medicines Deemed Essential by Oncologists in 82 Countries: An International, Cross-Sectional Survey Opens in a new window)
This international, cross-sectional survey was developed by investigators from a range of clinical practice settings across low-income to high-income countries, including members of the WHO Essential Medicines Cancer Working Group.Comments
-
Potential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending Opens in a new window)
President Biden has endorsed adding a hard cap on out-of-pocket Medicare Part D prescription drug spending.Comments
-
Voters Support Lowering the Medicare Eligibility Age and Prescription Drug Prices Opens in a new window)
As the coronavirus pandemic has shown us, there are many disparities in the United States in regards to healthcare coverage.Comments
-
How Would Drug Price Negotiation Affect Medicare Part D Premiums? Opens in a new window)
The debate over a budget reconciliation package in the coming weeks, and possibly months, is likely to focus heavily on the savings to Medicare, which can be used to expand Medicare benefits and fund other health care priorities.Comments
-
AbbVie's Blockade of Cheaper Humira Options Opens in a new window)
Cheaper versions of Humira exist, but Americans don't have access to them due entirely to AbbVie's "legal strategy" of delaying entry.Comments
-
'Erratic' FDA and Inconsistent Drug Decisions Put Doctors Off New Meds Opens in a new window)
Stunning reversals, surprise delays and controversial approvals are the order of the day at the FDA lately — and doctors have had enough.Comments
-
Recognizing Hepatitis R&D on World Hepatitis Day Opens in a new window)
World Hepatitis Day is a chance to celebrate medical advancements that have been life-changing for patients.Comments
-
Millions of Medicare Part D Enrollees Have Had Out-of-Pocket Drug Spending Above the Catastrophic Threshold Over Time Opens in a new window)
As new, high-priced drugs come to market and are covered under Medicare Part D, the current requirement for beneficiaries to pay a coinsurance of 5% in the catastrophic coverage phase can lead to thousands of dollars in out-of-pocket costs.Comments
-
The True Cost Of Food Is Three Times What Americans Pay For It Opens in a new window)
At $1.1 trillion, human health was by far the greatest driver of hidden food costs. It takes into account the share of direct medical costs attributable to diet as well as associated productivity loss.Comments
-
Indication-Based Pricing - Consultation Report
Should drug prices differ by indication?Comments
Comments